Terms and conditions for provision of compounds & material to CO-ADD

THE UNIVERSITY OF QUEENSLAND ABN 63 942 912 684, a body corporate constituted under the University of Queensland Act 1998 (Qld) of Brisbane, Queensland 4072

Delivery Address

Street Address: The Institute for Molecular Bioscience (Building 80), 306 Carmody Road, The University of Queensland

Suburb: St Lucia State: Queensland Postcode: 4072 Country: Australia

Material

_______________________________________________________

(Insert a description of all material to be provided including the volume or quantity and all relevant characteristics, eg. 20 vials each containing 1mg of chemically synthesised material)

The parties acknowledge and agree that if any Material is provided by the Provider to UQ, then that Material is provided on the basis of the Material transfer agreement terms and conditions annexed (or, if no terms and conditions are annexed, the Material transfer agreement terms and conditions made available by UQ from time to time).

Execution

Signed as an agreement.

SIGNED for and on behalf of

SIGNED for and on behalf of

THE UNIVERSITY OF

UNIVERSITY OF XXXX

by its duly authorised officer:

in the presence of:

by:

..............................................

Director

..............................................

Witness (Print Name)

..............................................

Director / Secretary

..............................................

Witness (Print Name)

Research Partnerships

..............................................

Date:

..............................................

Date:

..............................................

Date:

Background

A

The Provider wishes to provide the Material to The University of Queensland [UQ], which hosts the Community for Open Antimicrobial Drug Discovery [CO-ADD].

B

Provider agrees to provide and UQ agrees to receive the Material on the basis of these terms and conditions.

Operative terms

1 Definitions and interpretation

1.1

Definitions

In this Agreement:

Agreement

means this agreement as amended or replaced by agreement of the parties in writing from time to time.

Approved Purpose

means the screening of the Material provided for antimicrobial activity and for cytotoxicity as part of the Community for Open Antimicrobial Drug Discovery [CO- ADD].

Confidential Information

means any information disclosed by the Provider to The University of Queensland [UQ] in relation to the Material, except for information:

that UQ can show was already known to, in the rightful possession of or independently developed by UQ in good faith and free of any obligation of confidence; or

that UQ can show is in the public domain otherwise than by a breach of this Agreement or other obligation of confidence.

to the Provider’s knowledge and belief, infringe any 3rd party rights and obligations and will notify UQ in the event of any infringement. For clarity, the Provider warrants that Provider has the required permission to provide the material to UQ for the Approved Purpose.

2.3

Physical ownership

UQ acknowledges and agrees that, as between the parties, the Provider retains title to the Material provided to UQ under this Agreement.

3 Exclusion of warranties

UQ acknowledges and agrees that:

the Provider does not give any warranty that the Material is fit for any particular purpose; and

the Material is provided on an “as is” basis subject to 2.2.

4 Intellectual Property

4.1

Intellectual Property arising from use of the Material

UQ acknowledges that the Provider is the owner of New IP.

5 Confidentiality

5.1

Obligation of confidence

UQ must:

keep the Confidential Information of the Provider confidential;

only use the Confidential Information for the Approved Purpose;

5.2

Exception

The obligations of confidence contemplated by clause 5.1 do not apply to Confidential Information to the extent that the information is required to be disclosed under applicable law or in cases otherwise agreed by the parties.

The provider of the compound/s or material agrees to provide the chemical structures of the compound/s or material at the time of compound submission. CO-ADD agrees to keep said structures confidential for a period of 2 years from the date the primary screening report is sent. Thereafter the structure and associated data will be included in a publically accessible database, unless a further extension of the confidential period is requested in writing at least 4 weeks before the expiration of the 2 year period.

6 Term and termination

This Agreement commences on the date of receipt of Material by UQ and continues until terminated by a party in accordance with this clause 6.

If a party commits a material breach of this Agreement and fails to remedy that breach within 30 days of a written request by the other party, then the other party may terminate this Agreement by notice in writing to that party.

On termination of this Agreement:

accrued rights or remedies of a party are not affected; and

UQ must destroy or deliver to the Provider any Material and Confidential Information that was made available to UQ at the Provider’s discretion.

Termination of this Agreement will not affect any provision of this Agreement that is intended to come into force or continue after the termination including clauses 2.1, 2.3, 4 and 5.

VariationWe reserved the right to revise these terms and conditions from time to time.The revised terms and conditions shall apply from the date of publication of the revised terms and conditions on our website (http://www.co-add.org/content/terms)

Our detailsOur principal place of business is at 306 Carmody Road, St. Lucia Qld 4072, Australia.You can contact us by using our website contact form, by email to info@co-add.org

CO-ADD newsletter

Sign up to CO-ADD's mailing list to receive updates and invitations to events, seminars and activities